Antimalarial Drugs as Immune Modulators: New Mechanisms for Old Drugs

112Citations
Citations of this article
127Readers
Mendeley users who have this article in their library.

Abstract

The best known of the naturally occurring antimalarial compounds are quinine, extracted from cinchona bark, and artemisinin (qinghao), extracted from Artemisia annua in China. These and other derivatives are now chemically synthesized and remain the mainstay of therapy to treat malaria. The beneficial effects of several of the antimalarial drugs (AMDs) on clinical features of autoimmune disorders were discovered by chance during World War II. In this review, we discuss the chemistry of AMDs and their mechanisms of action, emphasizing how they may impact multiple pathways of innate immunity. These pathways include Toll-like receptors and the recently described cGAS-STING pathway. Finally, we discuss the current and future impact of AMDs on systemic lupus erythematosus, rheumatoid arthritis, and devastating monogenic disorders (interferonopathies) characterized by expression of type I interferon in the brain.

Cite

CITATION STYLE

APA

An, J., Minie, M., Sasaki, T., Woodward, J. J., & Elkon, K. B. (2017, January 14). Antimalarial Drugs as Immune Modulators: New Mechanisms for Old Drugs. Annual Review of Medicine. Annual Reviews Inc. https://doi.org/10.1146/annurev-med-043015-123453

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free